Dissolution testing of immediate-release products and its application to forecasting in vivo performance

Oral Drug Absorption: Prediction and Assessment

Volumn , Issue , 2000, Pages 155-181

  Dressman, Jennifer B ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36849080227     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (25)

1. Amidon GL, Lennernäs H, Shah VP, Crison JR. Theoretical basis for a biophar-maceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12: 413-420.
2. Rudman A, Williams R. Guidance for Industry: Immediate Release Solid Oral Dosage Forms. Scale-up and post-approval changes: Chemistry, manufacturing and controls, in vitro dissolution testing and in vivo bioequivalence documentation. Center for Drug Evaluation and Research, Food and Drug Administration, Nov. 1995. See also Draft Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification Scheme. FDA, 1999. (http://www.fda.gov/cder/guidance/index.htm)
3. Galia E, Nicolaides E, Hörter D, Löbenberg R, Reppas C, Dressman JB. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res 1998; 15: 698-705.
4. United States Pharmacopeia 24 and National Formulary 19. Rockville, MD: United States Pharmacopeial Convention, 1999.
5. Kabasakalian P, Katz M, Rosenkrantz B, Townley E. Parameters affecting absorption of griseofulvin in a human subject using urinary excretion data. J Pharm Sci 1970; 59: 595-600.
6. Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971; 60: 1281-1303.
7. Russell TL, Berardi RR, Barnett JL, O’Sullivan TL, Wagner JG, Dressman JB. pH-related changes in the absorption of dipyridamole in the elderly. Pharm Res 1994; 11: 136-143.
8. Lelawongs P, Barone JA, Colaizzi JL, Hsuan AT, Mechlinski W, Legendre R, Guarniere J. Effect of food and gastric acidity on absorption of orally administered ketoconazole. Clin Pharm 1988; 7: 228-235.
9. Efentakis M, Dressman JB. Gastric juice as a dissolution medium: surface tension and pH. Eur J Drug Metab Pharmacokinet 1998; 23: 97-102.
10. Finholt P, Solvang S. Dissolution kinetics of drugs in human gastric juice: the role of surface tension. J Pharm Sci 1968; 57: 1322-1326.
11. Dressman JB, Berardi RR, Dermentzoglou LC, Russell TL, Schmaltz SP, Barnett JL, Jarvenpaa KM. Upper gastrointestinal pH in young, healthy men and women. Pharm Res 1990; 7: 756-761.
12. Galia E, Horton J, Dressman JB. Albendazole generics: a comparative in vitro study. Pharm Res 1999; 16: 1872-1876.
13. Greenwood DE. Small Intestinal pH and Buffer Capacity: Implications for Dissolution of Ionizable Compounds. Doctoral dissertation. The University of Michigan, Ann Arbor, MI, 1994.
14. Mithani SD, Bakatselou V, TenHoor CN, Dressman JB. Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm Res 1996; 13: 163-167.
15. Fordtran JS, Lochlear T. Ionic constituents and osmolarity of gastric and small intestinal fluids after eating. Am J Dig Dis 1966; 11: 503-521.
16. Nicolaides E, Galia E, Efthymiopoulos C, Dressman JB, Reppas C. Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data. Pharm Res 1999; 16: 1877-1883.
17. Daneshmend TK, Warnock DW, Ene MD, Johnson EM, Potten MR, Richardson MD, Williamson PJ. Influence of food on the pharmacokinetics of ketoconazole. Antimicrob Agents Chemother 1984; 25: 1-3.
18. Charman WN, Rogge MC, Boddy AW, Barr WH, Berger BM. Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single and douhle peak phenomena in the plasma profiles. J Clin Pharmacol 1993; 33:1207-1213.
19. Young MA, Lettis S, Eastmond R. Improvement in the gastrointestinal absorption of troglitazone when taken with, or shortly after, food. Br J Clin Pharmacol 1998; 45: 31-35.
20. Stipplcr E, personal communication (University of Frankfurt).
21. Shah VP, Konecny JJ, Everett RL, McCullough B, Nooriazadeh AC, Skelly JP. In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants. Pharm Res 1989; 6: 612-618.
22. Abrahamsson B, Johansson D, Torstensson A, Wingstrand K. Evaluation of’solu-bilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine. Pharm Res 1994; 11: 1093-1097.
23. Dressman JB, Amidon GL, Reppas C, Shah VP. Dissolution testing as a prognostic tool for drug absorption: immediate release dosage forms. Pharm Res 1998; 15: 1 1-22.
24. Diebold S. personal communication (University of Frankfurt).
25. Dissolution testing of solid oral products. A joint report of the Section for Official Laboratories and Medicines Control Services and the Section of Industrial Pharmacists of the Federation Internationale Pharmaceutique. Dissolution Tech 1997; 4: 5-14.